http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103954761-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 |
| filingDate | 2014-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103954761-B |
| titleOfInvention | For oophoroma early metaphase quick diagnosis reagent kit and detection method thereof |
| abstract | The invention discloses one for oophoroma early metaphase quick diagnosis reagent kit, comprise the monoclonal antibody that CBP-35, transthyretin, cancer antigen-125 and people's epididymal proteins 4 make respectively; Described kit also comprises detection antibody, and described detection antibody comprises the polyclonal antibody that CBP-35, transthyretin, cancer antigen-125 and people's epididymal proteins 4 make respectively. Beneficial effect of the present invention is as follows: the most comprehensively detect oophoroma, can better judge before menopause or menopause after pelvic mass good pernicious, better the optimum Ovarian Tumor of gynaecology and tumour and oophoroma are carried out to antidiastole, have the advantages that highly sensitive accuracy is strong, its sensitivity and accuracy all reach more than 96%. |
| priorityDate | 2014-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.